In addition, in the clinical scenario of using desflurane for anesthesia, studies have found that miR-34a mimics or inhibitors targeting LOXL3 may play a potential protective role in colorectal cancer patients undergoing desflurane anesthesia, offering a new direction for optimizing the treatment regimens of such patients. Here, LOXL3 is linked to colorectal cancer.